BILL ANALYSIS                                                                                                                                                                                                    Ó



                                                                    SCR 108


                                                                    Page  1


          Date of Hearing:   April 14, 2016


                             ASSEMBLY COMMITTEE ON RULES


                                    Gordon, Chair


          SCR  
                       108 (Monning) - As Amended April 12, 2016


          SENATE VOTE:  40-0


          SUBJECT:  Rare Disease Day


          SUMMARY:  Proclaims February 29, 2016, as Rare Disease Day in  
          California and would provide for the recognition of Rare Disease  
          Day in California in subsequent years, as specified.   
          Specifically, this resolution makes the following legislative  
          findings:


           1) There are nearly 7,000 diseases and conditions that are  
             considered rare; and, rare diseases as a group affect almost  
             30 million Americans.

           2) Many rare diseases are serious and debilitating conditions  
             that have a significant impact on the lives of those  
             affected; and, individuals and their families affected by  
             rare diseases struggle with obtaining an accurate and timely  
             diagnosis, few, if any treatment options, and problems  
             related to accessing or being reimbursed for treatment.

           3) Nearly one in 10 Americans has a rare disease, Californians  
             are among those affected by those diseases.

           4) Every year on the last day of February a nationwide  
             observance of rare diseases is organized with patients,  








                                                                    SCR 108


                                                                    Page  2


             medical professionals, researchers, government officials, and  
             companies developing treatments for rare diseases.

          FISCAL EFFECT:  None


          REGISTERED SUPPORT / OPPOSITION:


          Support


          Bayer
          California Life Sciences Association


          Opposition
          None on file


          Analysis Prepared by:Nicole Willis / RLS. / (916) 319-2800